Affiliation:
1. From the Department of Cardiovascular Medicine (T.I., Y.K., T.Y., Y.I., K.I., Y.O., H.T., T.K.) and the Department of Molecular Biophysics (N.S., A.N.), Kyoto University Graduate School of Medicine, Kyoto, Japan.
Abstract
Background—
In ventricular myocardium, the T-type Ca
2+
current (
I
Ca,T
), which is temporarily observed during fetal and neonatal periods, has been shown to reappear in failing/remodeling hearts. However, its pathophysiological regulation has not been elucidated.
Methods and Results—
We utilized Dahl salt-sensitive (DS) rats with hypertension at the stage of concentric left ventricular (LV) hypertrophy (11 weeks old, LVH) and at the heart failure stage (16 to 18 weeks old, CHF). Some were treated with bosentan (100 mg/kg per day) during the period from LVH to CHF. In LVH, neither the presence of
I
Ca,T
(measured in the freshly isolated LV myocytes) nor an increase in α-1G mRNA expression were detected. This condition was associated with increases in tissue angiotensin II (AII) but not with endothelin (ET)-1 peptides. In contrast, in CHF, when the tissue AII remained elevated and ET-1 de novo increased,
I
Ca,T
was recorded in most of the cells (−0.87±0.18 pA/pF at −30 mV,
P
<0.01 versus LVH). This was associated with a significant increase in the α-1G mRNA level. The chronic bosentan treatment eliminated both the elevation of α-1G mRNA level and
I
Ca,T
from the cells, whereas it did not affect the cell size and membrane capacitance. In addition, 48-hour exposure to ET-1 but not AII induced
I
Ca,T
in normal adult myocytes in culture from Sprague-Dawley rats.
Conclusions—
I
Ca,T
channels reappear in failing but not in hypertrophied LV cardiomyocytes in a manner depending on the tissue ET-1 activation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献